https://orcid.org/0000-0001-9267-4536
Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jae C Chang. (2021) COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on “Two-Path Unifying Theory” of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy. Vascular Health and Risk Management 17, pages 273-298.
Read now
Read now
Giacomo Sgalla, Alessia Comes, Marialessia Lerede & Luca Richeldi. (2021) COVID-related fibrosis: insights into potential drug targets. Expert Opinion on Investigational Drugs 30:12, pages 1183-1195.
Read now
Read now
Stelios F. Assimakopoulos, Diamanto Aretha, Dimitris Komninos, Dimitra Dimitropoulou, Maria Lagadinou, Lydia Leonidou, Ioanna Oikonomou, Athanasia Mouzaki & Markos Marangos. (2021) N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: a two-center retrospective cohort study. Infectious Diseases 53:11, pages 847-854.
Read now
Read now
Mario Cazzola, Josuel Ora, Andrea Bianco, Paola Rogliani & Maria Gabriella Matera. (2021) Management of COPD patients during COVID: difficulties and experiences. Expert Review of Respiratory Medicine 15:8, pages 1025-1033.
Read now
Read now
Articles from other publishers (55)
Matthew T. J. Halma, Christof Plothe, Paul Marik & Theresa A. Lawrie. (2023) Strategies for the Management of Spike Protein-Related Pathology. Microorganisms 11:5, pages 1308.
Crossref
Crossref
Joël Pincemail, Anne-Françoise Rousseau, Jean-François Kaux, Jean-Paul Cheramy-Bien, Christine Bruyère, Jeanine Prick, David Stern, Mouna-Messaouda Kaci, Benoît Maertens De Noordhout, Adelin Albert, Céline Eubelen, Caroline Le Goff, Benoît Misset, Etienne Cavalier, Corinne Charlier & Smail Meziane. (2023) A Pilot Study on Oxidative Stress during the Recovery Phase in Critical COVID-19 Patients in a Rehabilitation Facility: Potential Utility of the PAOT® Technology for Assessing Total Anti-Oxidative Capacity. Biomedicines 11:5, pages 1308.
Crossref
Crossref
María Elena Soto, Linaloe Manzano-Pech, Adrían Palacios-Chavarría, Rafael Ricardo Valdez-Vázquez, Verónica Guarner-Lans & Israel Pérez-Torres. (2023) N-Acetyl Cysteine Restores the Diminished Activity of the Antioxidant Enzymatic System Caused by SARS-CoV-2 Infection: Preliminary Findings. Pharmaceuticals 16:4, pages 591.
Crossref
Crossref
John V. Schloss. (2023) Nutritional deficiencies that may predispose to long COVID. Inflammopharmacology 31:2, pages 573-583.
Crossref
Crossref
Xi-Qiu Xu, Tongran Xu, Wenting Ji, Chong Wang, Yujie Ren, Xiaobei Xiong, Xi Zhou, Shu-Hai Lin, Yi Xu & Yang Qiu. (2023) Herpes Simplex Virus 1-Induced Ferroptosis Contributes to Viral Encephalitis. mBio 14:1.
Crossref
Crossref
Oya KALE & Gülsen KESKİN. (2023) Investigation of supplement products preferred by healthcare professionals during COVID-19 pandemic processCOVID-19 pandemi sürecinde sağlık profesyonelleri tarafından tercih edilen takviye ürünlerin araştırılması. Journal of Contemporary Medicine 13:1, pages 107-113.
Crossref
Crossref
Voddu Suresh, Padmanava Behera, Deepti Parida, Amlan Priyadarshee Mohapatra, Suraja Kumar Das, Sneha Kumari, Kiran Avula, Amruta Mohapatra, Gulam Hussain Syed & Shantibhusan Senapati. (2023) Therapeutic role of N-acetyl cysteine (NAC) for the treatment and/or management of SARS-CoV-2-induced lung damage in hamster model. European Journal of Pharmacology 938, pages 175392.
Crossref
Crossref
Petra Itterheimová, Věra Dosedělová & Petr Kubáň. (2022) Use of metal nanoparticles for preconcentration and analysis of biological thiols. ELECTROPHORESIS 44:1-2, pages 135-157.
Crossref
Crossref
José Luis Izquierdo-Alonso, Sandra Pérez-Rial, Carolina Gotera Rivera & Germán Peces-Barba. (2022) N-acetylcysteine for prevention and treatment of COVID-19: Current state of evidence and future directions. Journal of Infection and Public Health 15:12, pages 1477-1483.
Crossref
Crossref
Andrea Bianco, Stefano Conte, Domenica Francesca Mariniello, Valentino Allocca, Maria Gabriella Matera, Vito D’Agnano, Luigi Lanata, Mario Cazzola & Fabio Perrotta. (2022) Mucolytic and Antioxidant Properties of Carbocysteine as a Strategy in COVID-19 Therapy. Life 12:11, pages 1824.
Crossref
Crossref
Anand Thirupathi, Yaodong Gu, Zsolt Radak & Ricardo A Pinho. (2022) Redox Status Is the Mainstay of SARS-CoV-2 and Host for Producing Therapeutic Opportunities. Antioxidants 11:10, pages 2061.
Crossref
Crossref
Marco Cosentino, Veronica Vernocchi, Stefano Martini, Franca Marino, Barbara Allasino, Maria Antonietta Bàlzola, Fabio Burigana, Alberto Dallari, Carlo Servo Florio Pagano, Antonio Palma & Mauro Rango. (2022) Early Outpatient Treatment of COVID-19: A Retrospective Analysis of 392 Cases in Italy. Journal of Clinical Medicine 11:20, pages 6138.
Crossref
Crossref
Nilay Aksoy, Cansu Vatansever, Gizem Zengin Ersoy, Basak Adakli Aksoy & Tunç Fışgın. (2022) The effect of biofilm inhibitor N-acetylcysteine on the minimum inhibitory concentration of antibiotics used in Gram-negative bacteria in the biofilm developed on catheters. The International Journal of Artificial Organs 45:10, pages 865-870.
Crossref
Crossref
Hong-Yu Liang, Yuyan Wu, Vicky Yau, Huan-Xin Yin, Scott Lowe, Rachel Bentley, Mubashir Ayaz Ahmed, Wenjing Zhao & Chenyu Sun. (2022) SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19. Vaccines 10:9, pages 1538.
Crossref
Crossref
Mojtaba Enayati, Sara Madarshahian, Bing Yan, Gerhard Ufheil & Alireza Abbaspourrad. (2022) Granulation and encapsulation of N-Acetylcysteine (NAC) by internal phase separation. Food Hydrocolloids 130, pages 107699.
Crossref
Crossref
Evangelia Eirini Tsermpini, Una Glamočlija, Fulden Ulucan-Karnak, Sara Redenšek Trampuž & Vita Dolžan. (2022) Molecular Mechanisms Related to Responses to Oxidative Stress and Antioxidative Therapies in COVID-19: A Systematic Review. Antioxidants 11:8, pages 1609.
Crossref
Crossref
Heidi N du Preez, Colleen Aldous, Hendrik G Kruger & Lin Johnson. (2022) N-Acetylcysteine and Other Sulfur-Donors as a Preventative and Adjunct Therapy for COVID-19. Advances in Pharmacological and Pharmaceutical Sciences 2022, pages 1-21.
Crossref
Crossref
Aaron M. Gusdon, Nauder FaradayJohn S. Aita, Sunil Kumar, Ishan Mehta, HuiMahn A. ChoiJeffery L. Cleland, Keith Robinson, Louise D. McCullough, Derek K. NgRangaramanujam M. Kannan & Sujatha Kannan. (2022) Dendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial. Science Translational Medicine 14:654.
Crossref
Crossref
Hongyan Li, Shuofeng Yuan, Xueying Wei & Hongzhe Sun. (2022) Metal-based strategies for the fight against COVID-19. Chemical Communications 58:54, pages 7466-7482.
Crossref
Crossref
Pratima Chowdary. (2022) COVID‐19 coagulopathy – what should we treat?. Experimental Physiology 107:7, pages 749-758.
Crossref
Crossref
Jonathan Foo, Gregory Bellot, Shazib Pervaiz & Sylvie Alonso. (2022) Mitochondria-mediated oxidative stress during viral infection. Trends in Microbiology 30:7, pages 679-692.
Crossref
Crossref
Eleni Pitsillou, Julia Liang, Andrew Hung & Tom C. Karagiannis. (2022) The SARS-CoV-2 helicase as a target for antiviral therapy: Identification of potential small molecule inhibitors by in silico modelling. Journal of Molecular Graphics and Modelling 114, pages 108193.
Crossref
Crossref
Guangbin ChenHongzhou Lu. (2022) Oral high-dose acetylcysteine: Effective against the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)?. Drug Discoveries & Therapeutics 16:3, pages 139-141.
Crossref
Crossref
Melford Chuka Egbujor, Maria Petrosino, Karim Zuhra & Luciano Saso. (2022) The Role of Organosulfur Compounds as Nrf2 Activators and Their Antioxidant Effects. Antioxidants 11:7, pages 1255.
Crossref
Crossref
Katarzyna Grudlewska-Buda, Natalia Wiktorczyk-Kapischke, Anna Budzyńska, Joanna Kwiecińska-Piróg, Jana Przekwas, Agnieszka Kijewska, Dominika Sabiniarz, Eugenia Gospodarek-Komkowska & Krzysztof Skowron. (2022) The Variable Nature of Vitamin C—Does It Help When Dealing with Coronavirus?. Antioxidants 11:7, pages 1247.
Crossref
Crossref
Małgorzata Iciek, Anna Bilska-Wilkosz, Michał Kozdrowicki & Magdalena Górny. (2022) Reactive Sulfur Compounds in the Fight against COVID-19. Antioxidants 11:6, pages 1053.
Crossref
Crossref
Bhavdeep Singh, Eli Eshaghian, Judith Chuang & Mihai Covasa. (2022) Do Diet and Dietary Supplements Mitigate Clinical Outcomes in COVID-19?. Nutrients 14:9, pages 1909.
Crossref
Crossref
Mihaela Stoia & Simona Oancea. (2022) Low-Molecular-Weight Synthetic Antioxidants: Classification, Pharmacological Profile, Effectiveness and Trends. Antioxidants 11:4, pages 638.
Crossref
Crossref
Alfredo J. Ibáñez. (2022) How Is Mass Spectrometry Tackling the COVID-19 Pandemic?. Frontiers in Analytical Science 2.
Crossref
Crossref
Runming Wang, Jasper Fuk-Woo Chan, Suyu Wang, Hongyan Li, Jiajia Zhao, Tiffany Ka-Yan Ip, Zhong Zuo, Kwok-Yung Yuen, Shuofeng Yuan & Hongzhe Sun. (2022)
Orally administered bismuth drug together with
N
-acetyl cysteine as a broad-spectrum anti-coronavirus cocktail therapy
. Chemical Science 13:8, pages 2238-2248.
Crossref
Crossref
Marta Guerini, Giorgia Condrò, Valeria Friuli, Lauretta Maggi & Paola Perugini. (2022) N-acetylcysteine (NAC) and Its Role in Clinical Practice Management of Cystic Fibrosis (CF): A Review. Pharmaceuticals 15:2, pages 217.
Crossref
Crossref
Sergio Pandolfi, Salvatore Chirumbolo, Giovanni Ricevuti, Luigi Valdenassi, Geir Bjørklund, Roman Lysiuk, Monica Daniela Doşa, Larysa Lenchyk & Serafino Fazio. (2021) Home pharmacological therapy in early COVID‐19 to prevent hospitalization and reduce mortality: Time for a suitable proposal. Basic & Clinical Pharmacology & Toxicology 130:2, pages 225-239.
Crossref
Crossref
Paola Faverio, Paola Rebora, Emanuela Rossi, Savino Del Giudice, Filippo Montanelli, Laura Garzillo, Sara Busnelli, Fabrizio Luppi, Maria Grazia Valsecchi & Alberto Pesci. (2022)
Impact of
N
-acetyl-l-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study
. ERJ Open Research 8:1, pages 00542-2021.
Crossref
Crossref
José Luis Izquierdo, Joan B Soriano, Yolanda González, Sara Lumbreras, Julio Ancochea, Christian Echeverry & José Miguel Rodríguez. (2022) Use of N-Acetylcysteine at high doses as an oral treatment for patients hospitalized with COVID-19. Science Progress 105:1, pages 003685042210745.
Crossref
Crossref
Heidi N. du Preez, Colleen Aldous, Melvin R. Hayden, Hendrik G. Kruger & Johnson Lin. (2021) Pathogenesis of COVID‐19 described through the lens of an undersulfated and degraded epithelial and endothelial glycocalyx. The FASEB Journal 36:1.
Crossref
Crossref
Xiaojie Bi, Wei Liu, Xuan Ding, Shuang Liang, Yufen Zheng, Xiaoli Zhu, Sheng Quan, Xiao Yi, Nan Xiang, Juping Du, Haiyan Lyu, Die Yu, Chao Zhang, Luang Xu, Weigang Ge, Xinke Zhan, Jiale He, Zi Xiong, Shun Zhang, Yanchang Li, Ping Xu, Guangjun Zhu, Donglian Wang, Hongguo Zhu, Shiyong Chen, Jun Li, Haihong Zhao, Yi Zhu, Huafen Liu, Jiaqin Xu, Bo Shen & Tiannan Guo. (2022) Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19. Cell Reports 38:3, pages 110271.
Crossref
Crossref
María Amparo Blanch-Ruiz, Raquel Ortega-Luna, Guillermo Gómez-García, Maria Ángeles Martínez-Cuesta & Ángeles Álvarez. (2021) Role of Neutrophil Extracellular Traps in COVID-19 Progression: An Insight for Effective Treatment. Biomedicines 10:1, pages 31.
Crossref
Crossref
Abbas Taher, Marjan Lashgari, Ladan Sedighi, Farshid Rahimi-bashar, Jalal Poorolajal & Maryam Mehrpooya. (2021) A pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome. Pharmacological Reports 73:6, pages 1650-1659.
Crossref
Crossref
Ali Fathi Jouzdani, Rezvan Heidarimoghadam, Maryam Hazhirkamal & Akram Ranjbar. (2021) Nanoantioxidant/Antioxidant Therapy in 2019-nCoV: A New Approach to Reactive Oxygen Species Mechanisms. Current Drug Therapy 16:4, pages 291-298.
Crossref
Crossref
A. H. Shntaif, N. A. Alrazzak, A. Bader & A. M. Almarzoqi. (2021) Determination the binding ability of N-acetyl cysteine and its derivatives with SARS-COV-2 main protease using molecular docking and molecular dynamics studies. The Ukrainian Biochemical Journal 93:5, pages 43-51.
Crossref
Crossref
Anna Maria Fratta Pasini, Chiara Stranieri, Domenico Girelli, Fabiana Busti & Luciano Cominacini. (2021) Is Ferroptosis a Key Component of the Process Leading to Multiorgan Damage in COVID-19?. Antioxidants 10:11, pages 1677.
Crossref
Crossref
Michael Kalafatis. (2021) COVID-19: A Serious Vascular Disease with Primary Symptoms of a Respiratory Ailment. The Journal of Applied Laboratory Medicine 6:5, pages 1099-1104.
Crossref
Crossref
Zhen W Mei, Xander M R van Wijk, Huy P Pham & Maximo J Marin. (2021) Role of von Willebrand Factor in COVID-19 Associated Coagulopathy. The Journal of Applied Laboratory Medicine 6:5, pages 1305-1315.
Crossref
Crossref
Don A. Davies, Aida Adlimoghaddam & Benedict C. Albensi. (2021) The Effect of COVID-19 on NF-κB and Neurological Manifestations of Disease. Molecular Neurobiology 58:8, pages 4178-4187.
Crossref
Crossref
Mario Cazzola, Paola Rogliani, Sundeep Santosh Salvi, Josuel Ora & Maria Gabriella Matera. (2021) Use of Thiols in the Treatment of COVID-19: Current Evidence. Lung 199:4, pages 335-343.
Crossref
Crossref
Alvaro Martinez Mesa, Eva Cabrera César, Elisa Martín-Montañez, Esther Sanchez Alvarez, Pilar Martinez Lopez, Yanina Romero-Zerbo, Maria Garcia-Fernandez & Jose Luis Velasco Garrido. (2021) Acute Lung Injury Biomarkers in the Prediction of COVID-19 Severity: Total Thiol, Ferritin and Lactate Dehydrogenase. Antioxidants 10:8, pages 1221.
Crossref
Crossref
Karina Karina, Iis Rosliana, Imam Rosadi, Siti Sobariah, Louis Martin Christoffel, Rita Novariani, Siti Rosidah, Novy Fatkhurohman, Yuli Hertati, Nurlaela Puspitaningrum, Wismo Reja Subroto, Irsyah Afini & Difky Ernanda. (2021) Phase I/II Clinical Trial of Autologous Activated Platelet-Rich Plasma (aaPRP) in the Treatment of Severe Coronavirus Disease 2019 (COVID-19) Patients. International Journal of Inflammation 2021, pages 1-10.
Crossref
Crossref
Gerry K. Schwalfenberg. (2021) N-Acetylcysteine: A Review of Clinical Usefulness (an Old Drug with New Tricks). Journal of Nutrition and Metabolism 2021, pages 1-13.
Crossref
Crossref
Khalid O. Alfarouk, Sari T. S. AlHoufie, Samrein B. M. Ahmed, Mona Shabana, Ahmed Ahmed, Saad S. Alqahtani, Ali S. Alqahtani, Ali M. Alqahtani, AbdelRahman M. Ramadan, Mohamed E. Ahmed, Heyam S. Ali, Adil Bashir, Jesus Devesa, Rosa A. Cardone, Muntaser E. Ibrahim, Laurent Schwartz & Stephan J. Reshkin. (2021) Pathogenesis and Management of COVID-19. Journal of Xenobiotics 11:2, pages 77-93.
Crossref
Crossref
Terrance L. Baker & Jack V. Greiner. (2021) Guidelines for Reopening a Nation in a SARS-CoV-2 Pandemic: A Path Forward. Medicina 57:5, pages 496.
Crossref
Crossref
Zemene Demelash Kifle, Akeberegn Gorems Ayele & Engidaw Fentahun Enyew. (2021) Drug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment. Journal of Environmental and Public Health 2021, pages 1-11.
Crossref
Crossref
José Manuel Pérez de la Lastra, Celia Andrés-Juan, Francisco J. Plou & Eduardo Pérez-Lebeña. (2021) Impact of Zinc, Glutathione, and Polyphenols as Antioxidants in the Immune Response against SARS-CoV-2. Processes 9:3, pages 506.
Crossref
Crossref
Ana C. Gadotti, Anna L. Lipinski, Franciane TF. Vasconcellos, Luis F. Marqueze, Eduardo BB. Cunha, Amanda C. Campos, Camila F. Oliveira, Andréa NM. Amaral, Cristina P. Baena, João P. Telles, Felipe F. Tuon & Ricardo A. Pinho. (2021) Susceptibility of the patients infected with Sars-Cov2 to oxidative stress and possible interplay with severity of the disease. Free Radical Biology and Medicine 165, pages 184-190.
Crossref
Crossref
Adrián Palacios Chavarría, Rafael Ricardo Valdez Vázquez, José Guillermo Domínguez Cherit, Héctor Herrera Bello, Humberto Castillejos Suastegui, Lidia Moreno-Castañeda, Gabriela Alanís Estrada, Fabián Hernández, Omar González-Marcos, Huitzilihuitl Saucedo-Orozco, Linaloe Manzano-Pech, Ricardo Márquez-Velasco, Verónica Guarner-Lans, Israel Pérez-Torres & Maria Elena Soto. (2021) Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19. Computational and Structural Biotechnology Journal 19, pages 1379-1390.
Crossref
Crossref
Pawel Grieb, Maciej Swiatkiewicz, Katarzyna Prus & Konrad Rejdak. (2021) Hypoxia may be a determinative factor in COVID-19 progression. Current Research in Pharmacology and Drug Discovery 2, pages 100030.
Crossref
Crossref